{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:59:29Z","timestamp":1791280769105,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf01697400","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T06:56:06Z","timestamp":1116140166000},"page":"132-139","source":"Crossref","is-referenced-by-count":89,"title":["Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells"],"prefix":"10.1007","volume":"64","author":[{"given":"R.","family":"Leo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Peest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Seibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Deicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01697400_CR1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4049\/jimmunol.130.3.1132","volume":"130","author":"KC Anderson","year":"1983","unstructured":"Anderson KC, Park EK, Bates MP, et al. (1983) Antigens on human plasma cells identified by monoclonal antibodies. J Immunol 130: 1132\u20131138","journal-title":"J Immunol"},{"key":"BF01697400_CR2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI111056","volume":"72","author":"B Barlogie","year":"1983","unstructured":"Barlogie B, Alexanian R, Gehan EA (1983) Marrow cytometry and prognosis in myeloma. J Clin Invest 72: 853\u2013861","journal-title":"J Clin Invest"},{"key":"BF01697400_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood.V66.2.338.338","volume":"66","author":"B Barlogie","year":"1985","unstructured":"Barlogie B, Alexanian R, Smith L, Dixon D, Smallwood L, Delasalle K (1985) Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 66: 338\u2013341","journal-title":"Blood"},{"key":"BF01697400_CR4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI112033","volume":"76","author":"B Barlogie","year":"1985","unstructured":"Barlogie B, Alexanian R, Pershouse M, Smallwood L, Smith L (1985) Cytoplasmic immunoglobulin content in multiple myeloma. J Clin Invest 76: 765\u2013769","journal-title":"J Clin Invest"},{"key":"BF01697400_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hon.2900060207","volume":"6","author":"B Barlogie","year":"1988","unstructured":"Barlogie B, Epstein J, Alexanian R (1988) Genotypic and phenotypic characteristics of multiple myeloma. Hernatol Oncol 6: 99\u2013102","journal-title":"Hernatol Oncol"},{"key":"BF01697400_CR6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V73.4.865.865","volume":"73","author":"B Barlogie","year":"1989","unstructured":"Barlogie B, Epstein J, Selvanayagam P, Alexanian R (1989) Plasma cell myeloma \u2014 new biological insights and advances in therapy. Blood 73: 865\u2013879","journal-title":"Blood"},{"key":"BF01697400_CR7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","volume":"87","author":"R Bartl","year":"1987","unstructured":"Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W (1987) Histologic classification and staging of multiple myeloma. Am J Clin Pathol 87: 342\u2013355","journal-title":"Am J Clin Pathol"},{"key":"BF01697400_CR8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1182\/blood.V61.4.718.718","volume":"61","author":"MP Braun","year":"1983","unstructured":"Braun MP, Martin PJ, Ledbetter JA, Hansen JA (1983) Granulocytes and cultured human fibroblasts express common acute lmphoblastic leukemia-associated antigens. Blood 61: 718\u2013725","journal-title":"Blood"},{"key":"BF01697400_CR9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood.V59.3.528.528","volume":"59","author":"PA Bunn","year":"1982","unstructured":"Bunn PA, Krasmow JS, Makuch RW, Schlam ML, Schechter GP (1982) Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood 59: 528\u2013535","journal-title":"Blood"},{"key":"BF01697400_CR10","first-page":"82","volume":"44","author":"B Camp Van","year":"1981","unstructured":"Camp B Van, Reynaert P, Broodtaerts L (1981) Studies on the origin of the precursor cells in multiple myeloma, macroglobulinaemia of Waldenstr\u00f6m and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution. Clin Exp Immunol 44: 82\u201389","journal-title":"Clin Exp Immunol"},{"key":"BF01697400_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V76.2.377.377","volume":"76","author":"B Camp Van","year":"1990","unstructured":"Camp B Van, Durie BGM, Spier C, et al. (1990) Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 76: 377\u2013382","journal-title":"Blood"},{"key":"BF01697400_CR12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/1097-0142(19870901)60:5<1060::AID-CNCR2820600522>3.0.CO;2-3","volume":"60","author":"A Carter","year":"1987","unstructured":"Carter A, Hocherman I, Linn S, Cohen Y, Tatarsky I (1987) Prognostic significance of plasma cell morphology in multiple myeloma. Cancer 60: 1060\u20131065","journal-title":"Cancer"},{"key":"BF01697400_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcp\/91.1.12","volume":"91","author":"CSP Chan","year":"1989","unstructured":"Chan CSP, Wormsley SB, Peter JB, Schlechter GP (1989) Dual parameter analysis of myeloma cells by flow cytometry. Am J Clin Pathol 91: 12\u201317","journal-title":"Am J Clin Pathol"},{"key":"BF01697400_CR14","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00591a005","volume":"18","author":"JW Chirgwin","year":"1979","unstructured":"Chirgwin JW, Przybyla AE, McDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleaic acid drom sources enriched with ribonuclease. Biochemistry 18: 5294\u20135299","journal-title":"Biochemistry"},{"key":"BF01697400_CR15","doi-asserted-by":"crossref","unstructured":"Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 842\u2013854","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"BF01697400_CR16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V66.1.229.229","volume":"66","author":"BGM Durie","year":"1985","unstructured":"Durie BGM, Grogan TM (1985) CALLA-positive myeloma: an aggressive subtype with poor survival. Blood 66: 229\u2013232","journal-title":"Blood"},{"key":"BF01697400_CR17","unstructured":"D\u00f6rken B, M\u00f6ller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G (1989) B-cell antigens: CD38. In: Knapp et al. (eds) Leucocyte typing, IV. Oxford University Press, p 86"},{"key":"BF01697400_CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2249.1991.tb05654.x","volume":"83","author":"J Drach","year":"1991","unstructured":"Drach J, Gattringer C, Huber H (1991) Expression of the neural adhesion molecule (CD56) by human myeloma cells. Clin Exp Immunol 83: 418\u2013422","journal-title":"Clin Exp Immunol"},{"key":"BF01697400_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V71.4.861.861","volume":"71","author":"J Epstein","year":"1988","unstructured":"Epstein J, Barlogie B, Katzmann J, Alexanian R (1988) Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 71: 861\u2013865","journal-title":"Blood"},{"key":"BF01697400_CR20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199003083221005","volume":"322","author":"J Epstein","year":"1990","unstructured":"Epstein J, Xiao H, He XY (1990) Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 322: 664\u2013668","journal-title":"N Engl J Med"},{"key":"BF01697400_CR21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V63.5.1072.1072","volume":"63","author":"E Fritz","year":"1984","unstructured":"Fritz E, Ludwig H, Kundi M (1984) Prognostic relevance of cellular morphology in multiple myeloma. Blood 63: 1072\u20131079","journal-title":"Blood"},{"key":"BF01697400_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1182\/blood.V62.1.166.166","volume":"62","author":"PR Greipp","year":"1983","unstructured":"Greipp PR, Kyle RA (1983) Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smouldering multiple myeloma. Blood 62: 166\u2013171","journal-title":"Blood"},{"key":"BF01697400_CR23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.V70.4.932.932","volume":"70","author":"TM Grogan","year":"1987","unstructured":"Grogan TM, Durie BGM, Lomen C, et al. (1987) Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features. Blood 70: 932\u2013942","journal-title":"Blood"},{"key":"BF01697400_CR24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood.V73.3.763.763","volume":"73","author":"TM Grogan","year":"1989","unstructured":"Grogan TM, Durie BGM, Spier CM, Richter L, Vela E (1989) Myelomonocytic antigen-positive multiple myeloma. Blood 73: 763\u2013769","journal-title":"Blood"},{"key":"BF01697400_CR25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI111794","volume":"75","author":"T Hercend","year":"1985","unstructured":"Hercend T, Griffin JD, Bensussan A, et al. (1985) Generation of monoclonal antibodies to a human natural killer clone: characterization of two natural killer cell antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 75: 932\u2013943","journal-title":"J Clin Invest"},{"key":"BF01697400_CR26","first-page":"351","volume":"72","author":"N Jackson","year":"1988","unstructured":"Jackson N, Ling NR, Ball J, Bromidge E, Nathan PD, Franklin IM (1988) An analysis of myeloma plasma cell phenotype using antibodies defined at the Third International Workshop on Human Leucocyte Differentiation Antigens. Clin Exp Immunol 72: 351\u2013356","journal-title":"Clin Exp Immunol"},{"key":"BF01697400_CR27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V73.7.1925.1925","volume":"73","author":"MA King","year":"1989","unstructured":"King MA, Nelson DS (1989) Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow. Blood 73: 1925\u20131935","journal-title":"Blood"},{"key":"BF01697400_CR28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA (1978) Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am J Med 64: 814\u2013826","journal-title":"Am J Med"},{"key":"BF01697400_CR29","doi-asserted-by":"crossref","unstructured":"Lanier LL, My Le A, Ding A, et al. (12987) Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and noncytotoxic T cell lines. J Immunol 138: 2019\u20132023","DOI":"10.4049\/jimmunol.138.7.2019"},{"key":"BF01697400_CR30","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1084\/jem.169.6.2233","volume":"169","author":"LL Lanier","year":"1989","unstructured":"Lanier LL, Testi R, Bindi J, Phillips JH (1989) Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169: 2233\u20132238","journal-title":"J Exp Med"},{"key":"BF01697400_CR31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V55.3.403.403","volume":"55","author":"J Latreille","year":"1980","unstructured":"Latreille J, Barlogie B, Dosik G, Johnston DA, Drewinko B, Alexanian R (1980) Cellular DNA content as a marker of human multiple myeloma. Blood 55: 403\u2013408","journal-title":"Blood"},{"key":"BF01697400_CR32","first-page":"1316","volume":"70","author":"MR Loken","year":"1987","unstructured":"Loken MR, Shah VO, Dattilio KL, Civin CI (1987) Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70: 1316\u20131324","journal-title":"II. Normal B lymphocyte development. Blood"},{"key":"BF01697400_CR33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.137.3.1075","volume":"137","author":"RT McCormack","year":"1986","unstructured":"McCormack RT, Nelson RD, Le Bien TW (1986) Structure\/ function studies of the common acute lymphoblastic leukemia antigen (CALLA\/CD10) expressed on human neutrophils. J Immunol 137: 1075\u20131082","journal-title":"J Immunol"},{"key":"BF01697400_CR34","first-page":"65","volume-title":"Clinics in haematology, vol. 11, no. 1","author":"H Mellstedt","year":"1982","unstructured":"Mellstedt H, Holm G, Pettersson D, Peest D (1982) Idiotype bearing lymphoid cells in plasma cell neoplasia. In: Salmon SE (ed) Clinics in haematology, vol. 11, no. 1. Saunders, London, pp 65\u201386"},{"key":"BF01697400_CR35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood.V49.3.379.379","volume":"49","author":"SE Salmon","year":"1977","unstructured":"Salmon SE, Wampler SE (1977) Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculator. Blood 49: 379\u2013389","journal-title":"Blood"},{"key":"BF01697400_CR36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1991.tb07975.x","volume":"77","author":"JF Miguel San","year":"1991","unstructured":"San Miguel JF, Gonzalez M, Gascon A, Moro MJ, Hernandez JM, Ortega F, Jimenez R, Guerras L, Romero M, Casanova F, Sanz MA, Sanchez J, Portero JA, Orfao A (1991) Immunophen\u00f6typic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Br J Haematol 77: 185\u2013190","journal-title":"Br J Haematol"},{"key":"BF01697400_CR37","first-page":"192","volume":"70","author":"PL Tazzari","year":"1987","unstructured":"Tazzari PL, Gobbi M, Dinota A, Bontadini A, Grassi G, Cerato C, Cavo M, Pileri S, Caligaris-Cappio F, Tura S (1987) Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol 70: 192\u2013200","journal-title":"Clin Exp Immunol"},{"key":"BF01697400_CR38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.V76.9.1739.1739","volume":"76","author":"LWMM Terstappen","year":"1990","unstructured":"Terstappen LWMM, Johnsen S, Segers-Nolten IMJ, Loken MR (1990) Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood 76: 1739\u20131747","journal-title":"Blood"},{"key":"BF01697400_CR39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2141.1989.tb07744.x","volume":"73","author":"N Tominaga","year":"1989","unstructured":"Tominaga N, Katagiri S, Ohnishi M, Nakao H, Oritani K, Yagura H, Tamaki T, Kanayama Y, Yonezawa T, Tarui S (1989) Analysis of surface antigen expression of human immunoglobulin-secreting cells: phenotypic heterogeneity in normal counterparts of myeloma cells. Br J Haematol 73: 302\u2013308","journal-title":"Br J Haematol"},{"key":"BF01697400_CR40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0277-5379(90)90035-R","volume":"26","author":"O Wetter","year":"1990","unstructured":"Wetter O, Brandhorst D, Reiter W (1990) Leu-19 in myeloma a new role for an old antibody. Eur J Cancer 26: 541","journal-title":"Eur J Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01697400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01697400\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01697400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:58:21Z","timestamp":1683097101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01697400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF01697400"],"URL":"https:\/\/doi.org\/10.1007\/bf01697400","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}